Payment of Interest & Principal
Piramal Enterprises Ltd has informed BSE regarding "Payment of Interest & Principal".08-01-2018
08-01-2018
Piramal Enterprises boosts OTC business with brand acquisitions
The OTC business of Piramal, already among the top five OTC specialists in the Rs 20,000 crore market, had revenues of Rs 375 crore in 2016-17, a jump of 44 per cent compared to the Rs 261 crore it posted in the previous year.05-12-2017
Outcome of Board Meeting
Outcome of Board Meeting held today - Mr. Vivek Valsaraj to discharge role of Chief Financial Officer of the Company01-12-2017
Piramal acquires Digeplex from Shreya Lifesciences
Piramal Enterprises today acquired the Digeplex and the associated brands from Shreya Lifesciences for an undisclosed sum to expand its consumer products business. The acquisition will help the...30-11-2017
Allotment
Intimation with respect to allotment of Equity shares pursuant to optional conversion of Compulsorily Convertible Debentures ('CCDs')24-11-2017
Analyst / Investor Meet - Intimation
Intimation of Conference Call with Investors/ Analysts under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201524-11-2017
No immediate plans to integrate Shriram business with PEL: Ajay Piramal
Piramal is one of the major shareholders, beside Shriram Employees Trust & South African financial conglomerate Sanlam in Shriram Capital18-11-2017
Analyst / Investor Meet - Outcome
Transcript of Conference Call with Investors/Analysts held on 9th November, 201716-11-2017
Analyst / Investor Meet - Intimation
Intimation of Conference Call with Investors/ Analysts under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201508-11-2017